Impaired Nrf2 Signaling in Friedreich Ataxia
Author Information
Author(s): Paupe Vincent, Dassa Emmanuel P., Goncalves Sergio, Auchère Françoise, Lönn Maria, Holmgren Arne, Rustin Pierre
Primary Institution: Inserm, U676, Hôpital Robert Debré, Paris, France
Hypothesis
The study investigates the impairment of the Nrf2 signaling pathway in Friedreich ataxia and its role in oxidative stress response.
Conclusion
The defective Nrf2 signaling pathway in Friedreich ataxia cells leads to increased susceptibility to oxidative stress due to impaired antioxidant enzyme induction.
Supporting Evidence
- FRDA fibroblasts showed hypersensitivity to oxidative insults due to impaired Nrf2 signaling.
- Nrf2 failed to translocate to the nucleus in FRDA fibroblasts in response to oxidative stress.
- Treatment with the catalase mimetic Euk134 restored Nrf2 signaling in FRDA cells.
- Induction of phase II antioxidant genes was significantly impaired in FRDA cells.
Takeaway
Friedreich ataxia cells have trouble fighting off damage from harmful substances because they can't use a key protein called Nrf2 properly.
Methodology
The study used cultured fibroblasts from patients with Friedreich ataxia to assess the Nrf2 signaling pathway and its response to oxidative stress.
Limitations
The study primarily focuses on fibroblasts, which may not fully represent neuronal responses in Friedreich ataxia.
Participant Demographics
Fibroblasts from four healthy controls and four patients with Friedreich ataxia.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website